Status:
COMPLETED
Cardiovascular System in Obesity: Effect of Treatment
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Heart Diseases
Obesity
Eligibility:
All Genders
18-60 years
Phase:
PHASE2
Brief Summary
To determine the long-term efficacy of the combination therapy of phentermine and fenfluramine in conjunction with diet, exercise, and behavior modification in the treatment of simple, moderate obesit...
Detailed Description
BACKGROUND: Obesity is a problem of significant public health concern both in this and other western countries. One reason is that it is a risk factor for cardiovascular disease, most notably hyperte...
Eligibility Criteria
Men and women, ages 18 to 60. Body weight was 130 to 180 percent of ideal body weight.
Key Trial Info
Start Date :
May 1 1983
Trial Type :
INTERVENTIONAL
End Date :
April 1 1988
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00000506
Start Date
May 1 1983
End Date
April 1 1988
Last Update
November 26 2013
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.